Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$19.72 - $28.68 $234,668 - $341,292
11,900 Added 32.31%
48,728 $1.34 Million
Q1 2023

May 11, 2023

SELL
$20.58 - $27.89 $36,529 - $49,504
-1,775 Reduced 4.6%
36,828 $821,000
Q4 2022

Feb 08, 2023

SELL
$15.31 - $29.94 $34,233 - $66,945
-2,236 Reduced 5.48%
38,603 $916,000
Q3 2022

Nov 14, 2022

SELL
$16.58 - $27.9 $79,650 - $134,031
-4,804 Reduced 10.53%
40,839 $678,000
Q2 2022

Aug 10, 2022

BUY
$15.45 - $29.52 $25,368 - $48,471
1,642 Added 3.73%
45,643 $908,000
Q1 2022

May 11, 2022

SELL
$21.94 - $42.51 $343,163 - $664,898
-15,641 Reduced 26.22%
44,001 $1.21 Million
Q3 2021

Nov 10, 2021

BUY
$35.62 - $52.97 $1.24 Million - $1.85 Million
34,846 Added 140.53%
59,642 $2.77 Million
Q2 2021

Aug 10, 2021

BUY
$32.94 - $56.62 $11,957 - $20,553
363 Added 1.49%
24,796 $991,000
Q1 2021

May 14, 2021

SELL
$44.47 - $81.38 $254,768 - $466,226
-5,729 Reduced 18.99%
24,433 $1.31 Million
Q4 2020

Feb 11, 2021

SELL
$32.49 - $61.88 $53,381 - $101,668
-1,643 Reduced 5.17%
30,162 $1.48 Million
Q3 2020

Nov 12, 2020

SELL
$26.73 - $35.67 $3,020 - $4,030
-113 Reduced 0.35%
31,805 $1.03 Million
Q2 2020

Aug 13, 2020

SELL
$19.49 - $28.11 $788,994 - $1.14 Million
-40,482 Reduced 55.91%
31,918 $827,000
Q1 2020

May 13, 2020

BUY
$16.13 - $30.17 $743,593 - $1.39 Million
46,100 Added 175.29%
72,400 $1.76 Million
Q4 2019

Feb 14, 2020

BUY
$20.78 - $29.99 $546,514 - $788,737
26,300 New
26,300 $734,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.14B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.